RA0438

antibody from Oursmab

Targeting: KDR CD309, FLK1, VEGFR, VEGFR2

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0438

Provider

Oursmab

Product name

Pulocimab (Biosimilar Reference Antibody) (KDR)

Antibody type

Monoclonal

Description

Pulocimab is a humanized IgG1 monoclonal antibody targeting VEGFR-2 (KDR). It works by binding to and blocking this key receptor for vascular endothelial growth factor (VEGF), thereby inhibiting the signaling pathway that promotes tumor angiogenesis (new blood vessel formation). This action aims to starve tumors of oxygen and nutrients, suppressing their growth and metastasis in various solid cancers.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Pulocimab (Biosimilar Reference Antibody) (KDR)-RA0438-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Pulocimab biosimilar in a linear range of 3.91-500 ng/mL.